X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (188) 188
Publication (32) 32
Patent (7) 7
Book Chapter (6) 6
Government Document (2) 2
Book / eBook (1) 1
Conference Proceeding (1) 1
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (108) 108
female (75) 75
oncology (67) 67
index medicus (51) 51
animals (48) 48
ovarian cancer (44) 44
cell line, tumor (42) 42
ovarian neoplasms - genetics (33) 33
mice (32) 32
ovarian neoplasms - pathology (32) 32
cancer (29) 29
apoptosis (26) 26
cell biology (26) 26
expression (26) 26
article (24) 24
biochemistry & molecular biology (24) 24
ovarian neoplasms - metabolism (23) 23
gene expression regulation, neoplastic (21) 21
mice, nude (21) 21
genetics & heredity (20) 20
middle aged (19) 19
ovarian neoplasms - drug therapy (19) 19
aged (18) 18
carcinoma (18) 18
cells (17) 17
chemotherapy (17) 17
growth (17) 17
molecular sequence data (17) 17
proteins (16) 16
tumor cells, cultured (16) 16
base sequence (15) 15
high-temperature requirement a serine peptidase 1 (14) 14
immunohistochemistry (14) 14
endocrine system diseases (13) 13
gene (13) 13
xenograft model antitumor assays (13) 13
breast-cancer (12) 12
down-regulation (12) 12
identification (12) 12
male (12) 12
reverse transcriptase polymerase chain reaction (12) 12
serine endopeptidases - metabolism (12) 12
survival (12) 12
apoptosis - drug effects (11) 11
dna methylation (11) 11
gene expression (11) 11
sulfotransferases - metabolism (11) 11
adult (10) 10
aged, 80 and over (10) 10
analysis (10) 10
genes (10) 10
polymerase chain reaction (10) 10
research (10) 10
serine endopeptidases - genetics (10) 10
sulfotransferases - genetics (10) 10
amino acid sequence (9) 9
drug synergism (9) 9
gene expression profiling (9) 9
gene-expression (9) 9
genetic aspects (9) 9
htra1 (9) 9
methylation (9) 9
neoplasm staging (9) 9
obstetrics and gynecology (9) 9
research article (9) 9
care and treatment (8) 8
chromosome mapping (8) 8
chromosomes, human, pair 3 (8) 8
cisplatin (8) 8
female genital diseases and pregnancy complications (8) 8
heterozygosity (8) 8
lung-cancer (8) 8
metastasis (8) 8
multidisciplinary sciences (8) 8
mutation (8) 8
obstetrics & gynecology (8) 8
ovarian-cancer (8) 8
resistance (8) 8
signal transduction (8) 8
survival analysis (8) 8
tumor-suppressor gene (8) 8
tumors (8) 8
angiogenesis (7) 7
cell proliferation (7) 7
chemoresistance (7) 7
cisplatin - pharmacology (7) 7
cloning, molecular (7) 7
dna (7) 7
family (7) 7
genes, tumor suppressor (7) 7
health aspects (7) 7
hsulf-1 (7) 7
in-vivo (7) 7
investigating or analysing materials by determining theirchemical or physical properties (7) 7
lung neoplasms - genetics (7) 7
measuring (7) 7
physics (7) 7
prognosis (7) 7
protein (7) 7
testing (7) 7
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Frontiers in Oncology, ISSN 2234-943X, 2014, Volume 4, p. 195
Heparan sulfate proteoglycans (HSPGs) are an integral and dynamic part of normal tissue architecture at the cell surface and within the extracellular matrix.... 
Heparan sulfate | Heparanase | cancer therapy | tumor microenvironment targeting | SULF1 | Sulf2
Journal Article
Frontiers in Oncology, ISSN 2234-943X, 2013, Volume 3
Despite several advances in the understanding of ovarian cancer pathobiology, in terms of driver genetic alterations in high-grade serous cancer, histology... 
Platinum resistance | Cancer stem cell | Extracellular matrix | Ovarian cancer | Platinum-sensitive recurrence | platinum-sensitive recurrence | Extracellular Matrix | ovarian cancer | platinum resistance
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 01/2013, Volume 8, Issue 1, p. e54578
Ovarian cancer (OvCa) is the fifth most common cause of death from all cancers among women in United Sates and the leading cause of death from gynecological... 
CELLS | ACTIVATION | METASTASIS | BEVACIZUMAB | MULTIDISCIPLINARY SCIENCES | CERIUM OXIDE NANOPARTICLES | IN-VIVO | PHASE-II | TUMOR ANGIOGENESIS | KRABBE-DISEASE | ENDOTHELIAL GROWTH-FACTOR | Reactive Oxygen Species | Nanoparticles - chemistry | Cerium - chemistry | Humans | Ovarian Neoplasms - pathology | Cerium - pharmacology | Cerium - pharmacokinetics | Neoplasm Metastasis | Nanoparticles - therapeutic use | Female | Ovarian Neoplasms - metabolism | Ovarian Neoplasms - drug therapy | Disease Models, Animal | Signal Transduction | Endothelial Cells - metabolism | Nanoparticles - ultrastructure | Angiogenesis Inhibitors - pharmacology | Angiogenesis Inhibitors - pharmacokinetics | Cell Movement - drug effects | Animals | Tumor Burden - drug effects | Mice, Nude | Neovascularization, Pathologic - drug therapy | Cell Line, Tumor | Vascular Endothelial Growth Factors - metabolism | Cell Proliferation - drug effects | Mice | Angiogenesis Inhibitors - chemistry | Endothelial Cells - drug effects | Antimitotic agents | Chemotherapy | Cerium | Antineoplastic agents | Vascular endothelial growth factor | Health aspects | Ovarian cancer | Cancer | Cell proliferation | Rare earth metals | Ovarian carcinoma | Laboratories | Staining | Cancer therapies | Defects | Nanoparticles | Antioxidants | Angiogenesis | Signal transduction | Reduction | Epidermal growth factor | Surgery | Inhibition | Cerium oxides | Mass spectroscopy | Pharmacology | Electron microscopy | SDF-1 protein | Patients | Chemical compounds | Endothelial cells | Gelatinase A | Medicine | Pathology | Inductively coupled plasma | Transmission electron microscopy | Womens health | Antiangiogenics | Medical prognosis | Capillary tubes | Cell migration | Tumors | Apoptosis
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 01/2016, Volume 22, Issue 2 Supplement, pp. PR08 - PR08
Journal Article
Science, ISSN 0036-8075, 11/2006, Volume 314, Issue 5801, pp. 992 - 993
Journal Article
Current Cancer Drug Targets, ISSN 1568-0096, 06/2009, Volume 9, Issue 4, pp. 451 - 468
The human HtrA family of serine proteases consists of four members: HtrA1, HtrA2, HtrA3 and HtrA4. Although prokaryotic HtrA proteins are well characterized in... 
ONCOLOGY | ACUTE LYMPHOBLASTIC-LEUKEMIA | PROSTATE-CANCER | GENE-EXPRESSION PROFILES | CLEAR-CELL SARCOMA | AMYLOID PRECURSOR PROTEIN | DRUG-RESISTANCE | HISTONE DEACETYLASE INHIBITORS | HUMAN BREAST-CANCER | APOPTOSIS PROTEINS | EPITHELIAL OVARIAN-CANCER
Journal Article
International Journal of Cancer, ISSN 0020-7136, 03/2013, Volume 132, Issue 5, pp. 1201 - 1212
Angiogenesis is a hallmark of tumor development and metastatic progression, and anti‐angiogenic drugs targeting the VEGF pathway have shown to decrease the... 
plumbagin | ovarian cancer | angiogenesis | cytotoxicity | APOPTOSIS | DEPENDENT PHOSPHORYLATION | OXIDATIVE STRESS | ACTIVATION | PROTEIN | TRANSCRIPTION | P53 | CHEMOTHERAPEUTIC-AGENTS | ONCOLOGY | PROSTATE-CANCER | ENDOTHELIAL GROWTH-FACTOR | Platelet Endothelial Cell Adhesion Molecule-1 - genetics | Calcium - metabolism | Humans | Ovarian Neoplasms - pathology | Glucose Transporter Type 1 - metabolism | Ki-67 Antigen - metabolism | Vascular Endothelial Growth Factor A - metabolism | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Vascular Endothelial Growth Factor A - genetics | Tumor Suppressor Protein p53 - genetics | Neovascularization, Pathologic - pathology | Cell Transformation, Neoplastic - genetics | Platelet Endothelial Cell Adhesion Molecule-1 - metabolism | Female | Antineoplastic Agents - pharmacology | Ovarian Neoplasms - metabolism | Ovarian Neoplasms - blood supply | Ovarian Neoplasms - drug therapy | Endothelial Cells - metabolism | Tumor Suppressor Protein p53 - metabolism | Angiogenesis Inhibitors - pharmacology | Naphthoquinones - pharmacology | Cisplatin - pharmacology | Random Allocation | Mice, SCID | Cell Transformation, Neoplastic - metabolism | Xenograft Model Antitumor Assays | Animals | BRCA2 Protein - metabolism | Glucose Transporter Type 1 - genetics | Ki-67 Antigen - genetics | Neovascularization, Pathologic - drug therapy | Cell Line, Tumor | Cell Proliferation - drug effects | Mice | Cell Transformation, Neoplastic - drug effects | Antineoplastic Agents, Phytogenic - pharmacology | Cell Transformation, Neoplastic - pathology | Endothelial Cells - pathology | BRCA2 Protein - genetics | Endothelial Cells - drug effects | Medical colleges | Care and treatment | Oncology, Experimental | Development and progression | Metastasis | Research | Ovarian cancer | Endothelium | Prevention | Analysis | Cancer cells | Tumor proteins | Vascular endothelial growth factor | Cancer | Medical research | Angiogenesis | Chemotherapy | Tumors | Cytotoxicity | Plumbagin
Journal Article
Scientific Reports, ISSN 2045-2322, 12/2018, Volume 8, Issue 1, pp. 2487 - 12
We have previously shown that the anti-malarial compound Quinacrine (QC) inhibits ovarian cancer (OC) growth by modulating autophagy. In the present study we... 
PROGRAMMED CELL-DEATH | BREAST-CANCER | LUNG-CANCER | APOPTOSIS | SUPPRESSES TUMORIGENESIS | CARCINOMA CELLS | MULTIDISCIPLINARY SCIENCES | RESISTANCE | DEGRADATION | SKP2 | PROGRESSION | RNA, Small Interfering - genetics | Apoptosis - drug effects | Humans | Cyclin-Dependent Kinase Inhibitor p27 - agonists | Gene Expression Regulation, Neoplastic | Apoptosis - genetics | RNA, Messenger - metabolism | Autophagy - drug effects | Tumor Suppressor Protein p53 - genetics | Cyclin-Dependent Kinase Inhibitor p27 - metabolism | Ovary | Quinacrine - pharmacology | Cyclin-Dependent Kinase Inhibitor p21 - genetics | S-Phase Kinase-Associated Proteins - antagonists & inhibitors | Cyclin-Dependent Kinase Inhibitor p21 - metabolism | Cell Cycle Checkpoints - genetics | Female | Antineoplastic Agents - pharmacology | Autophagy - genetics | Sequestosome-1 Protein - metabolism | Signal Transduction | RNA, Messenger - genetics | Sequestosome-1 Protein - antagonists & inhibitors | Tumor Suppressor Protein p53 - metabolism | Drug Repositioning | S-Phase Kinase-Associated Proteins - metabolism | Antimalarials - pharmacology | Sequestosome-1 Protein - genetics | Cyclin-Dependent Kinase Inhibitor p21 - agonists | Cell Cycle Checkpoints - drug effects | Cell Line, Tumor | S-Phase Kinase-Associated Proteins - genetics | Cyclin-Dependent Kinase Inhibitor p27 - genetics | RNA, Small Interfering - metabolism | Cycle protein | GTP-binding protein | Quinacrine | p53 Protein | F-box protein | mRNA | Tumor cell lines | Autophagy | Ovarian cancer | Proteins | Cyclin-dependent kinase inhibitor p21 | Cell lines | Cell cycle | Phagocytosis | Apoptosis
Journal Article
International Journal of Cancer, ISSN 0020-7136, 01/2019, Volume 144, Issue 1, pp. 178 - 189
Metabolic alterations are increasingly recognized as important novel anti‐cancer targets. Among several regulators of metabolic alterations, fructose 2,6... 
lipid droplet | PFKFB3 | ovarian and cervical cancer | lipophagy | Chemoresistance | CELLS | APOPTOSIS | PHOSPHORYLATION | 6-PHOSPHOFRUCTO-2-KINASE PFKFB3 | OVARIAN-CANCER | AUTOPHAGY | ONCOLOGY | RESISTANCE | HSULF-1 | LIPID DROPLETS | ADIPOSE-TISSUE | Lipid Droplets - drug effects | Apoptosis - drug effects | Humans | Enzyme Inhibitors - pharmacology | Ovarian Neoplasms - pathology | Phosphofructokinase-2 - antagonists & inhibitors | Carboplatin - administration & dosage | Glycolysis - drug effects | Autophagy - drug effects | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Drug Synergism | Xenograft Model Antitumor Assays | Animals | Phosphofructokinase-2 - metabolism | Mice, Nude | Cell Line, Tumor | Female | Ovarian Neoplasms - metabolism | Lipid Droplets - metabolism | Paclitaxel - administration & dosage | Ovarian Neoplasms - drug therapy | Drug Resistance, Neoplasm - drug effects | Antimitotic agents | Care and treatment | Antineoplastic agents | Health aspects | Analysis | Cancer | Regulators | Immunoprecipitation | Bafilomycin A | Lipids | Metabolism | Fructose | Metastases | Proteins | Alterations | Chemotherapy | Transmission electron microscopy | Inhibitors | Cell lines | Paclitaxel | Weight reduction | Glycolysis | Carboplatin | Lactic acid | Immunofluorescence | Ascites | Tumors | Apoptosis | Cancer Therapy and Prevention
Journal Article